Congestive heart failure in rheumatic carditis: Valvular or myocardial origin?  by Edwards, Brooks S. & Edwards, Jesse E.
830
Editorial Comment
Congestive Heart Failure lirn
Rheumatic Carditis: VaIvular or
Myocardial Origln?*
BROOKS S . EDWARDS, MD, FACC,
JESSE E. ED WARDS, MD, FACCt
Rochester, St . Paul and Minneapolis, Minnesota
A concept generally held is that congestive heart failure may
be caused by active rheumatic carditis . This concept is
questioned by Essop and coworkers (1) of Johannesburg in
their study appearing in this issue of the Journal . These
investigators reported on 32 young patients (all < 19 years
old) having active rheumatic c,,rditis and congestive heart
failure with pulmonary edema . All 32 patients underwent
valve replacement because of valvular regurgitation ; in
19 patients, only the mitral valve was replaced; the re-
maining 13 underwent both aortic and mitral valve replace-
ment. Echocardiographic evaluations were available for
analysis of studies done preoperatively and 3 months post
operatively .
Rheumatic mitral regurgitation. Preoperatively, when
compared with control subjects, each patient showed in-
creased left ventricular end-diastolic diameter and percent
fractional shortening. When studied about 3 months postop-
eratively, the left ventricular end-diastolic diameter had
decreased significantly and fractional shortening had re-
turned to the normal range. The investigators concluded that
the congestive failure was caused by the valvular regurgita-
tion rather than by the rheumatic myocarditis . This conclu-
sion is a departure from the long-standing teaching that
congestive heart failure in patients with active rheumatic
myocarditis is caused by the myocarditis . One finding sup-
porting that concept was the frequent subsidence of conges-
tive heart failure and mitral regurgitation as active rheumatic
myocarditis subsided . An alternative explanation for the
improved myocardial and valvular function is that the rest
prescribed for active rheumatic carditis reduced the de-
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mands on the circulation and that, in borderline cases, the
severity of mitral regurgitation may have decreased .
Some selective basis may also be operative, because
complete data are available for only 32 of the 43 patients
who presented with rheumatic carditis . Could those with
more active rheumatic myocarditis have had a higher
surgical mortality rate and thus not have been available
for follow-up 3 months postoperatively? Despite these
concerns, the investigators provide compelling data that,
at least in selected patients, myocardial contractile func-
tion is clearly adequate for valve replacement which, in
reality, is the clinically relevant question . To determine
whether or not there is a subtle defect in contractile
function would require more sophisticated analysis, and
its detection may have little relevance for the affected
patient .
The basis for the older concept that myocardial involve-
ment is important is somewhat blurred by semantics, in
which the terms "active" and "acute" rheumatic cardifis
tend to be used interchangeably .
It is universal knowledge that active rheumatic cardifis,
once present, has a tendency to recur . Moreover, some
episodes of activity go unnoticed, as judged by the high
incidence of active rheumatic myocarditis among patients
subjected to the old closed commissurotomy (2) . For the
patient whose earliest episodes of active rheumatic myocar-
ditis are silent, a recurrence may be labeled as the first attack
and has a chance of being designated "acute carditis ." In
such a situation, congestive heart failure, if present, could be
considered more likely to be of myocardial origin rather than
a result of organic valvular disease .
Among the patients of Essop and associates (1), those
with mitral regurgitation might be concluded to have had
incompetence of the mitral valve as a result of ventricular
dilation from rheumatic myocarditis . However, histologic
examination in patients with active rheumatic myocarditis
does not permit easy acceptance of this concept, because the
lesions of active myocarditis are primarily interstitial with-
out evidence of cellular myocardial necrosis . In this context,
it is reasonable that mitral regurgitation is caused by recur-
rent episodes of rheumatic endocarditis with recurrent heal-
ing and fibrosis of valvular tissue rather than the result of
myocarditis .
Rheumatic aortic regurgitation . Adding strength to the
concept that previous and recurrent episodes of active
rheumatic carditis caused mitral regurgitation is the presence
in the current study (I) of some patients with aortic valve
regurgitation . Although the hypothetic basis or mitral regur-
gitation may have an element of contribution by the myo-
cardial failure, aortic regurgitation of rheumatic origin
strongly indicates an element of intrinsic valvular rather than
myocardial disease. Thus, the fellLures of the case material,
as they relate to aortic valve regurgitation, add conceptual
support for the authors' conclusion .
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Parenthetically, the lesion of the posterior wall_ of the left
atrium seem in ame patients with active rheumatic carditis,
the so-called MacCallum patch, is more likely a "jet lesion"
from mitral regurgitation than a specific rheumatic lesion of
active rheumatic carditis (3) . During the silence of recurrent
active rheumatic carditis, chronic organic valvular disease
may develop and its consequences point to the innocent
myocardium rather than to the true perpetrator, the vaivular
endocardium .
Conclusions. 1i is probable that in dealing clinically with
patients having active rheumatic carditis, it is virtually
impossible to be certain that a given episode is the first,
namely acute rheumatic carditis . One has to accept that of
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so-called first episodes of acute rheumatic carditis many are,
iu fact, first recognized episodes in a disease with recurrent
and silent activity .
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